title: [Erythropoietin treatment in Piedmont and Valle d'Aosta].
abstract: The paper reports a study carried out in the Dialysis Centres of Piedmont and the Aosta Valley on the use of erythropoietin in the treatment of anemia in patients undergoing regular dialysis. The efficacy of the drug and collateral and/or undesirable effects were evaluated. It was found that the drug was efficacious in 99.2% of the 342 patients receiving treatment on 30-6-1990, whereas undesirable effects were observed in 14.6% of cases. Data from the Nephrology and Dialysis Service in Asti are also reported.
authors.affiliation: Servizio di Nefrologia e Dialisi, USSL n. 68, Asti.
authors.forename: P
authors.initials: P
authors.lastname: Imarisio
authors.forename: E
authors.initials: E
authors.lastname: Biamino
authors.forename: P
authors.initials: P
authors.lastname: Bongiorno
authors.forename: F
authors.initials: F
authors.lastname: Caligaris
authors.forename: G
authors.initials: G
authors.lastname: Demicheli
authors.forename: G
authors.initials: G
authors.lastname: Montalcini
authors.forename: A
authors.initials: A
authors.lastname: Arnaud
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000097:blood / Q000209:etiology / Q000628:therapy*; D004909:Erythrocyte Indices; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007155:Immunologic Factors / Q000009:adverse effects / Q000627:therapeutic use*; D007558:Italy; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis
chemical_list: D007155:Immunologic Factors; D011993:Recombinant Fusion Proteins; D004921:Erythropoietin
vernacular_title: Il trattamento con eritropoietina in Piemonte e Valle d'Aosta.